Kezar Life Sciences

KZR62

High Growth

$7.50arrow_drop_down1.04%-$0.08

High Growth

KZR62

$7.50

arrow_drop_down1.04%-$0.08

High Growth

Performance History

Key Stats
Open	$7.50
Prev. Close	$7.62
EPS	-13.12
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$54.72M
PE Ratio	-

	LOW	HIGH
Day Range	7.31	7.62
52 Week Range	0.52	8.43

Ratios







EPS	-13.12

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Kezar Life Sciences (KZR)

Kezar Life Sciences Inc (KZR) is a biotechnology company focused on the discovery and development of novel small molecule therapeutics to treat autoimmune diseases and cancer. The company's proprietary drug discovery platform utilizes its expertise in protein degradation to target disease-causing proteins for degradation, leading to the development of potential new therapies.

One of the key factors that investors often consider when evaluating a company's stock is its historical stock price. Looking at the stock price history of Kezar Life Sciences Inc (KZR), we can see that it has experienced significant fluctuations over the years. The stock price has ranged from a low of $10.50 to a high of $27.80 over the past 52 weeks. This volatility can be attributed to various factors, such as market conditions, industry trends, and company-specific news.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. John Franklin Fowler
Headquarters: South San Francisco
Employees: 84
Exchange: NASDAQ

Keep an eye on Kezar Life Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Kezar Life Sciences 's (KZR) price per share?

The current price per share for Kezar Life Sciences (KZR) is $7.5. The stock has seen a price change of -$0.08 recently, indicating a -1.05% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Kezar Life Sciences (KZR)?

For Kezar Life Sciences (KZR), the 52-week high is $8.43, which is 12.44% from the current price. The 52-week low is $0.52, the current price is 1.34K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Kezar Life Sciences (KZR) a growth stock?

Kezar Life Sciences (KZR) has shown an average price growth of -3.66% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Kezar Life Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Kezar Life Sciences (KZR) stock price performance year to date (YTD)?

As of the latest data, Kezar Life Sciences (KZR) has a year-to-date price change of -21.05%. Over the past month, the stock has experienced a price change of -6.6%. Over the last three months, the change has been 19.29%. Over the past six months, the figure is 2.94%. Looking at a longer horizon, the five-year price change stands at -73.31%.

help

Is Kezar Life Sciences (KZR) a profitable company?

Kezar Life Sciences (KZR) has a net income of -$101.87M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.42K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $7M, although specific revenue growth data is currently not available. Operating income is noted at -$105.24M. Furthermore, the EBITDA is -$98.46M.

help

What is the market capitalization of Kezar Life Sciences (KZR)?

Kezar Life Sciences (KZR) has a market capitalization of $54.72M. The average daily trading volume is 7.55, indicating the stock's liquidity and investor engagement.